Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:211-215, doi:10.1016/j.jacc.2008.03.045
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kallergis, E. M.
Right arrow Articles by Vardas, P. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kallergis, E. M.
Right arrow Articles by Vardas, P. E.
Related Collections
Right arrowRelated Article

Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation

Biochemical Assessment of Collagen Type-I Turnover

Eleftherios M. Kallergis, MD*, Emmanuel G. Manios, MD*, Emmanuel M. Kanoupakis, MD*, Hercules E. Mavrakis, MD*, Dimitris A. Arfanakis, MD*, Niki E. Maliaraki, MD{dagger}, Chrisovalantis E. Lathourakis, MD*, Gregory I. Chlouverakis, PhD* and Panos E. Vardas, MD, PhD, FESC, FACC*,*

* Department of Cardiology, University Hospital of Heraklion, Crete, Greece
{dagger} Laboratory of Biochemistry, University Hospital of Heraklion, Crete, Greece.


Figure 1
View larger version (7K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Comparative Levels of Serum Concentration of CICP

C-terminal propeptide of collagen type-I (CICP) showed a gradual increase from control subjects to paroxysmal and then to persistent atrial fibrillation (AF) patients as shown in this box plot.

 

Figure 2
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Box Plot of Serum Concentrations of CITP

C-terminal telopeptide of collagen type-I (CITP) in control subjects differed significantly compared with that in both paroxysmal and persistent atrial fibrillation (AF) patients.

 

Figure 3
View larger version (7K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Intergroup Serum Concentrations of MMP-1

This box plot depicts matrix metalloproteinase (MMP)-1 levels that differed significantly between persistent and paroxysmal atrial fibrillation (AF) patients.

 

Figure 4
View larger version (7K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Box Plot Depiction of the Differences in Levels of Serum TIMP-1

Tissue inhibitor of matrix metalloproteinase (TIMP)-1 levels differed significantly in all intergroup comparisons. AF = atrial fibrillation.

 

Figure 5
View larger version (8K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Direct Correlation Between Serum Concentrations of CICP and LA Diameter Dimensions

In all AF patients taken together, there was a positive correlation between CICP and left atrial diameter (LA) dimension (r = 0.635, p < 0.001). Abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement